OTR3   (Organ, Tissue, Regeneration, Repair and Replacement)

 is an innovative company dedicated to the development of the Matrix Therapy in regenerative medicine with a new class of therapeutic agents, the RGTA® (ReGeneraTing Agents).

The first two products developed from the RGTA® technology are:

  • CACIPLIQ20®, cutaneous wound healing kit, prescribed for the treatment of chronic skin wounds including arteritic and venous ulcers, diabetic foot and pressure ulcers.
  • CACICOL20®, single-dose eye drops for corneal healing prescribed for chronic corneal lesions.

 

 

Presentations of CACICOL20® : 12th World Ophtalmology Congress, February 16th - 20th, Abu Dhabi, UAE

Presentations of CACIPLIQ20®: Conference at the « Plastic Surgery Club », February 21th, Riyadh, Saudi Arabia  

OTR3

4 Rue Française
75001 PARIS     
contact us
tel+33(0)1 83 64 23 00
fax+33(0)9 55 72 44 53